We have shown that NLRC5 renders B16F10 mouse melanoma cells highly immunogenic via upregulating MHC-I and APP genes that facilitates the processing and presentation of endogenous tumor antigenic peptides [36]. The gene discussed is NLRC5; the disease is melanoma.